Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo

The effects of standard clinical therapies including surgery and chemotherapy are poor in advanced gallbladder cancer (GBC). There are a few reported cases of human epidermal growth factor receptor 2 (HER2)-positive GBC that responded well to trastuzumab. But trastuzumab has not yet been used to tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Hu, Zhenhua, Huang, Yu, Zheng, Huilin, Sun, Qiang, Yang, Qifan, Zhang, Yuan, Zhang, Linshi, Wang, Weilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452559/
https://www.ncbi.nlm.nih.gov/pubmed/31019975
http://dx.doi.org/10.1155/2019/9205851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452559/
https://www.ncbi.nlm.nih.gov/pubmed/31019975
http://dx.doi.org/10.1155/2019/9205851

Ejemplares similares